Emerging clinical and autopsy evidence points to late-onset epilepsy as a potentially distinct, neurodegeneration-related ...

They can manifest as a series of unusual behaviors, such as staring, twitching, confusion, and even loss of consciousness. Epileptic seizures are among the most common central nervous system disorders ...

One of the most common causes of epilepsy is a structural brain abnormality. “Epilepsy can result from structural issues in ...

The International League Against Epilepsy (ILAE) has revised its classification of seizure types to improve nomenclature, add new seizure types, and give clinicians the ability to classify seizures ...

Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More About 1.2 percent of people in the U.S. — and 3.4 million worldwide — ...

What Is a Seizure and What Is Epilepsy? Seizures, abnormal movements or behavior due to unusual electrical activity in the brain, are a symptom of epilepsy. But not all people who appear to have ...

If you don't know anybody who has epilepsy, you probably tend to think of it in one form: big, dramatic seizures (usually brought on by flashing lights or brain tumors) that involve bodily spasms, ...

Please provide your email address to receive an email when new articles are posted on . An analysis of 51 plasma proteins associated with immune response identified four proteins capable of confirming ...

Levetiracetam reduces tonic-clonic seizures by over 77% in clinical studies. Ethosuximide is highly effective for absence seizures, especially in children. Valproate remains the gold standard for ...

Children and young adults with a rare, debilitating type of epilepsy experienced half as many seizures while taking a cannabinoid drug, found a new study. A small handful of the study participants ...

GLP-1 receptor agonists were tied to a 16% lower risk of epilepsy in adults with type 2 diabetes. Epilepsy is an ...

A novel Kv7 potassium channel opener, may offer a unique treatment option for patients with resistant focal onset seizures.